ALDH3A1 blocking peptide product blog
Tags: ALDH3A1; Blocking Peptide; ALDH3A1 blocking peptide;
The ALDH3A1 aldh3a1 (Catalog #MBS9227316) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The ALDH3A1 aldh3a1 product has the following accession number(s) (GI #311033473) (NCBI Accession #P30838.3) (Uniprot Accession #P30838). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
ALDHs play a major role in the detoxification of alcohol-derived acetaldehyde. They are involved in the metabolism of corticosteroids, biogenic amines, neurotransmitters, and lipid peroxidation. This protein preferentially oxidizes aromatic aldehyde substrates. It may play a role in the oxidation of toxic aldehydes.
Cellular Location: Cytoplasm. Tissue Location: High levels in stomach, esophagus and lung; low level in the liver and kidney. ALDH3A1 also interacts with the following gene(s): ADH1B, ADH4, ADH5, ADH7, GSTA1. The following patways have been known to be associated with this gene. Breast Neoplasms, Carcinoma, Inflammation, Liver Diseases, Liver Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Experimental, Nervous System Diseases, Stomach Neoplasms are some of the diseases may be linked to ALDH3A1 Antibody (N-term) Blocking Peptide. Brain, Eye, Intestine, Liver, Lung, Mouth, Prostate, Skin, Stomach, Testis tissues are correlated with this protein.